ALL vs IRD · P/E 4.9, $56.89B cap vs rev $11.0M
The Allstate Corporation (ALL) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
ALL does not have a complete income-statement cache yet.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. IRD currently screens at market cap $35.7M.
Not investment advice. Open the ALL and IRD stock pages for the full models.
Not investment advice.